One Stop Shop for All Your Market Research Reports

Global Pimozide Market 2018 Industry Research Report

This report studies the global market size of Pimozide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pimozide in these regions. This research report categorizes the global Pimozide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis. Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval. The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years. The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%. Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%. In 2017, the global Pimozide market size was 12 million US$ and is forecast to 11 million US in 2025, growing at a CAGR of -0.9% from 2018. The objectives of this study are to define, segment, and project the size of the Pimozide market based on company, product type, application and key regions. The various contributors involved in the value chain of Pimozide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pimozide include Teva Par Pharmaceutical Johnson & Johnson Eumedica Pharmascience Domina Pharmaceuticals Aa Pharma Market Size Split by Type 1Mg 2Mg 4Mg Market Size Split by Application Hospitals Drugstores Others Market size split by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Pimozide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025. To understand the structure of Pimozide market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Pimozide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Pimozide with respect to individual growth trends, future prospects, and their contribution to the total market. To project the value and volume of Pimozide submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Pimozide are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pimozide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Study Coverage 1.1 Pimozide Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Pimozide Market Size Growth Rate by Type 1.4.2 1Mg 1.4.3 2Mg 1.4.4 4Mg 1.5 Market by Application 1.5.1 Global Pimozide Market Size Growth Rate by Application 1.5.2 Hospitals
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Corporate User US $7800
About this Report
Report ID 273519
Category
  • Pharmaceuticals and Healthcare
Published on 10-Oct
Number of Pages 115
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(58)